• Most Popular
  • Most Shared

Eli Lilly wins ok for dog separation anxiety drug

Wed Apr 25, 2007 8:00am EDT

Stocks

   

BOSTON, April 25 (Reuters) - Drugmaker Eli Lilly and Co. (LLY.N) said on Wednesday that it won U.S. regulatory approval for its drug to treat separation anxiety in dogs.

The drug, Reconcile, is one of a class of drugs known as selective serotonin reuptake inhibitors, or SSRIs, which are also used to treat human depression.

((Reporting by Toni Clarke, editing by Gerald E. McCormick; Reuters Messaging, toni.clarke.reuters.com@reuters.net, 617-367-4165)) Keywords: LILLY/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWEN6989



More from Reuters

U.S. Speaker of the House Nancy Pelosi (C) is surrounded by reporters as she walks towards the U.S. House of Representatives chamber to begin the vote on health care reform on Capitol Hill in Washington, March 21, 2010. REUTERS/Larry Downing

Democrats face dubious voters

Democrats in Congress who passed historic legislation to revamp the healthcare system face a new challenge: convincing voters it's a good deal.  Full Article | Video 

A soldier guards hundreds of bags of wheat seed in the isolated district of Nad Ali's district centre in the west of Helmand province, October 17, 2009

Dirty money and Afghan war

As the war in Afghanistan enters its ninth year, the U.S. has finally realized the best way to stop the conflict is to cut the flow of drug money, columnist Bernd Debusmann writes.   Commentary 

    An H1N1 flu vaccine inoculation is given at the Geisinger Medical Center in Danville, Pennsylvania October 28, 2009. REUTERS/Brad Bower

    A new stab at conquering pain

    Millions of people worldwide suffer chronic pain that can last weeks, months or years but relief may be on the way.  Full Article